To explore differences in (i) past-year use of GLP-1 or GLP-1/GIP medication to support weight loss and (ii) interest in using a weight-loss medication in the next year between population subgroups, we estimated these proportions stratified by gender, age, ethnicity, occupational social grade, financial situation, health-related economic inactivity, smoking status, alcohol consumption, past-month distress, and history of eating disorders
Further investigation is needed to understand the underlying mechanisms
was supported by funding from the NIH NIDDK (K01 DK132461)
Your flamingo is waiting.
However, once received, store the vials unconstituted in a freezer set to -20C for optimal long-term preservation